Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

HIV Infection

Free Subscription 19.11.2018 2 AIDS Res Hum Retroviruses 2 Antimicrob Agents Chemother 1 Blood 6 Clin Infect Dis 1 HIV Med 15 J Acquir Immune Defic Syndr 1 J Infect Dis 1 J Med Virol 5 J Virol 1 JAMA 1 Lancet 1 Lancet Glob Health 2 Lancet HIV 1 N Engl J Med 1 Nat Med 1 Nature 1 Pediatr Infect Dis J 11 PLoS One 2 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS Res Hum Retroviruses

1. CHIMUKANGARA B, Kharsany AB, Lessells RJ, Naidoo K, et al
   Moderate to high levels of pre-treatment HIV drug resistance in KwaZulu-Natal Province, South Africa.
   AIDS Res Hum Retroviruses. 2018 Nov 15. doi: 10.1089/AID.2018.0202.
   PubMed     Text format     Abstract available
   
   
2. VASYLYEVA TI, Liulchuk M, du Plessis L, Fearnhill E, et al
   The changing epidemiological profile of HIV-1 subtype B epidemic in Ukraine.
   AIDS Res Hum Retroviruses. 2018 Nov 15. doi: 10.1089/AID.2018.0167.
   PubMed     Text format     Abstract available
   
   

   
   Antimicrob Agents Chemother

3. MEIKLE V, Mossberg AK, Mitra A, Hakansson AP, et al
   A protein complex from human milk enhances the activity of antibiotics and drugs against Mycobacterium tuberculosis.
   Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01846.
   PubMed     Text format     Abstract available
   
   
4. WALIMBWA SI, Lamorde M, Waitt C, Kaboggoza J, et al
   DRUG INTERACTIONS BETWEEN DOLUTEGRAVIR AND ARTEMETHER-LUMEFANTRINE OR ARTESUNATE-AMODIAQUINE.
   Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01310.
   PubMed     Text format     Abstract available
   
   

   
   Blood

5. GANSNER JM, Rahmani M, Jonsson AH, Fortin BM, et al
   Plateletpheresis-associated lymphopenia in frequent platelet donors.
   Blood. 2018 Nov 14. pii: blood-2018-09-873125. doi: 10.1182/blood-2018-09-873125
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

6. CLARKE MA, Cheung LC, Lorey T, Hare B, et al
   Five-year prospective evaluation of cytology, HPV testing, and biomarkers for detection of anal precancer in HIV+ MSM.
   Clin Infect Dis. 2018 Nov 12. pii: 5174235. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
7. HOENIGL M, Moser C, Funderburg N, Bosch R, et al
   Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression.
   Clin Infect Dis. 2018 Nov 12. pii: 5174324. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
8. MUTSAERTS EAML, Nunes MC, van Rijswijk MN, Klipstein-Grobusch K, et al
   Measles immunity at 4.5 years of age following vaccination at 9 and 15-18 months of age among HIV-infected, HIV-exposed-uninfected and HIV-unexposed children.
   Clin Infect Dis. 2018 Nov 12. pii: 5174340. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
9. CREW PE, Abara WE, McCulley L, Waldron PE, et al
   Disseminated gonococcal infections in patients receiving eculizumab: a case series.
   Clin Infect Dis. 2018 Nov 12. pii: 5173471. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
10. NORRIS AH, Shrestha NK, Allison GM, Keller SC, et al
    2018 IDSA Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy.
    Clin Infect Dis. 2018 Nov 13. pii: 5175018. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
11. VAN DUIN D, Gu P, Dong J, Pfaff M, et al
    China-United States Research Collaborations in Antimicrobial Resistance.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available
    
    

    
    HIV Med

12. WILTON J, Light L, Gardner S, Rachlis B, et al
    Late diagnosis, delayed presentation and late presentation among persons enrolled in a clinical HIV cohort in Ontario, Canada (1999-2013).
    HIV Med. 2018 Nov 14. doi: 10.1111/hiv.12686.
    PubMed     Text format     Abstract available
    
    

    
    J Acquir Immune Defic Syndr

13. JUMARE J, El-Kamary SS, Magder L, Hungerford L, et al
    Body Mass Index and Cognitive Function among HIV-1 Infected Individuals in China, India and Nigeria.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001906.
    PubMed     Text format     Abstract available
    
    
14. FAINI D, Kalinjuma AV, Katende A, Mbwaji G, et al
    Laboratory-reflex cryptococcal antigen screening is associated with a survival benefit in Tanzania.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001899.
    PubMed     Text format     Abstract available
    
    
15. EL KAMARI V, Sattar A, McComsey GA
    Gut structural damage, an ongoing process in chronically untreated HIV infection.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001910.
    PubMed     Text format     Abstract available
    
    
16. COLON K, Speicher DW, Smith P, Taylor M, et al
    S100a14 is Increased in Activated Nk Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-Nk crosstalk.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001911.
    PubMed     Text format     Abstract available
    
    
17. TORTELLI BA, Char DM, Crane JS, Powderly WG, et al
    Comfort discussing HIV pre-exposure prophylaxis with patients among physicians in an urban emergency department.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001890.
    PubMed     Text format    
    
    
18. ARPADI S, Lamb M, Isaie Nzeyimana N, Vandebriel G, et al
    Better outcomes among HIV-infected Rwandan children 18-60 months following the implementation of "treat all".
    J Acquir Immune Defic Syndr. 2018 Nov 12. doi: 10.1097/QAI.0000000000001907.
    PubMed     Text format     Abstract available
    
    
19. VENTER WDF, Kambugu A, Chersich MF, Becker S, et al
    Efficacy and safety of tenofovir disoproxil fumarate versus low-dose stavudine over 96 weeks: a multi-country randomised, non-inferiority trial.
    J Acquir Immune Defic Syndr. 2018 Nov 12. doi: 10.1097/QAI.0000000000001908.
    PubMed     Text format     Abstract available
    
    
20. PHILLIPS TK, Wilson IB, Brittain K, Zerbe A, et al
    Decreases in self-reported ART adherence predict HIV viremia among pregnant and postpartum South African women.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001909.
    PubMed     Text format     Abstract available
    
    
21. BILLOCK RM, Powers KA, Pasquale DK, Samoff E, et al
    Prediction OF HIV Transmission Cluster Growth with Statewide Surveillance Data.
    J Acquir Immune Defic Syndr. 2018 Nov 5. doi: 10.1097/QAI.0000000000001905.
    PubMed     Text format     Abstract available
    
    
22. LEWIS L, Maughan-Brown B, Grobler A, Cawood C, et al
    The impact of home-based HIV testing services on progress towards the UNAIDS 90-90-90 targets in a hyperendemic area of South Africa.
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001900.
    PubMed     Text format     Abstract available
    
    
23. WELD ED, Rana MS, Dallas RH, Camacho-Gonzalez AF, et al
    Interest of Youth Living with HIV in Long-Acting Antiretrovirals.
    J Acquir Immune Defic Syndr. 2018 Nov 8. doi: 10.1097/QAI.0000000000001896.
    PubMed     Text format     Abstract available
    
    
24. RENTSCH CT, Tate JP, Steel T, Butt AA, et al
    Medical intensive care unit admission among patients with and without HIV, hepatitis C virus, and alcohol-related diagnoses in the United States: a national, retrospective cohort study, 1997-2014.
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001904.
    PubMed     Text format     Abstract available
    
    
25. COSTAGLIOLA D, Potard V, Lang S, Abgrall S, et al
    Impact of antiretroviral drugs on fracture risk in HIV-infected individuals: A case-control study nested within the French Hospital Database on HIV (FHDH-ANRS CO4).
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001903.
    PubMed     Text format     Abstract available
    
    
26. GRIFFITH D, Snyder J, Dell S, Nolan K, et al
    Impact of a youth-focused care model on retention and virologic suppression among young adults with HIV cared for in an adult HIV clinic.
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001902.
    PubMed     Text format     Abstract available
    
    
27. BLUMENTHAL J, Jain S, Mulvihill E, Sun S, et al
    Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men.
    J Acquir Immune Defic Syndr. 2018 Oct 29. doi: 10.1097/QAI.0000000000001888.
    PubMed     Text format     Abstract available
    
    

    
    J Infect Dis

28. VERBOEKET SO, Wit FW, Kirk GD, Drummond MB, et al
    Reduced Forced Vital Capacity among HIV-infected middle-aged individuals.
    J Infect Dis. 2018 Nov 12. pii: 5173872. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Med Virol

29. MALAGNINO V, Bottero J, Miailhes P, Lascoux-Combe C, et al
    Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection.
    J Med Virol. 2018 Nov 15. doi: 10.1002/jmv.25360.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

30. KIBLER KV, Asbach B, Perdiguero B, Garcia-Arriaza J, et al
    Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC.
    J Virol. 2018 Nov 14. pii: JVI.01513-18. doi: 10.1128/JVI.01513.
    PubMed     Text format     Abstract available
    
    
31. KUMAR S, Panda H, Makhdoomi MA, Mishra N, et al
    An HIV-1 broadly neutralizing antibody from a clade C infected pediatric elite neutralizer potently neutralizes the contemporaneous and autologous evolving viruses.
    J Virol. 2018 Nov 14. pii: JVI.01495-18. doi: 10.1128/JVI.01495.
    PubMed     Text format     Abstract available
    
    
32. ASBACH B, Kibler KV, Kostler J, Perdiguero B, et al
    Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost.
    J Virol. 2018 Nov 14. pii: JVI.01529-18. doi: 10.1128/JVI.01529.
    PubMed     Text format     Abstract available
    
    
33. CASTILLO-MENENDEZ LR, Nguyen HT, Sodroski J
    Conformational Differences Between Functional Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
    J Virol. 2018 Nov 14. pii: JVI.01709-18. doi: 10.1128/JVI.01709.
    PubMed     Text format     Abstract available
    
    
34. ANAND SP, Prevost J, Baril S, Richard J, et al
    Two families of Env antibodies efficiently engage Fc-gamma receptors and eliminate HIV-1-infected cells.
    J Virol. 2018 Nov 14. pii: JVI.01823-18. doi: 10.1128/JVI.01823.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

35. RUBIN R
    Have Tent, Will Do Pop-up HIV Screening.
    JAMA. 2018 Nov 7. pii: 2714379. doi: 10.1001/jama.2018.16245.
    PubMed     Text format    
    
    

    
    Lancet

36. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-infe
    Lancet. 2018 Nov 9. pii: S0140-6736(18)32462.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Glob Health

37. COMETTO G, Ford N, Pfaffman-Zambruni J, Akl EA, et al
    Health policy and system support to optimise community health worker programmes: an abridged WHO guideline.
    Lancet Glob Health. 2018;6:e1397-e1404.
    PubMed     Text format     Abstract available
    
    

    
    Lancet HIV

38. GOGA A
    Birth HIV testing and paediatric treatment programmes.
    Lancet HIV. 2018 Nov 8. pii: S2352-3018(18)30291.
    PubMed     Text format    
    
    
39. TECHNAU KG, Strehlau R, Patel F, Shiau S, et al
    12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study.
    Lancet HIV. 2018 Nov 8. pii: S2352-3018(18)30251.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

40. MEINTJES G, Stek C, Blumenthal L, Thienemann F, et al
    Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    N Engl J Med. 2018;379:1915-1925.
    PubMed     Text format     Abstract available
    
    

    
    Nat Med

41. IMPERIAL MZ, Nahid P, Phillips PPJ, Davies GR, et al
    Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis.
    Nat Med. 2018 Nov 14. pii: 10.1038/s41591-018-0294.
    PubMed     Text format     Abstract available
    
    

    
    Nature

42. LEWIN SR
    Combination treatment prevents HIV re-emergence in monkeys.
    Nature. 2018;563:333-335.
    PubMed     Text format    
    
    

    
    Pediatr Infect Dis J

43. JUMARE J, Datong P, Osawe S, Okolo F, et al
    Compromised Growth among HIV Exposed Uninfected Compared to Unexposed Children in Nigeria.
    Pediatr Infect Dis J. 2018 Nov 9. doi: 10.1097/INF.0000000000002238.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

44. PARBHOO S, Gottesman O, Ross AS, Komorowski M, et al
    Improving counterfactual reasoning with kernelised dynamic mixing models.
    PLoS One. 2018;13:e0205839.
    PubMed     Text format     Abstract available
    
    
45. KUMAR GA, Dandona R, Rewari BB, Kumar SGP, et al
    Decreasing cost of public sector first-line ART services in India from 2007-2008 to 2015-2016.
    PLoS One. 2018;13:e0206988.
    PubMed     Text format     Abstract available
    
    
46. HAKIM AJ, Coy K, Patnaik P, Telly N, et al
    An urgent need for HIV testing among men who have sex with men and transgender women in Bamako, Mali: Low awareness of HIV infection and viral suppression among those living with HIV.
    PLoS One. 2018;13:e0207363.
    PubMed     Text format     Abstract available
    
    
47. STEPHENSON KE, Keefer MC, Bunce CA, Frances D, et al
    First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
    PLoS One. 2018;13:e0205139.
    PubMed     Text format     Abstract available
    
    
48. SOLIS-REYES S, Avino M, Poon A, Kari L, et al
    An open-source k-mer based machine learning tool for fast and accurate subtyping of HIV-1 genomes.
    PLoS One. 2018;13:e0206409.
    PubMed     Text format     Abstract available
    
    
49. BROEKHUIS JM, Scarsi KK, Sayles HR, Klepser DG, et al
    Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV.
    PLoS One. 2018;13:e0207372.
    PubMed     Text format     Abstract available
    
    
50. PENNER J, Ferrand RA, Richards C, Ward KA, et al
    The impact of vitamin D supplementation on musculoskeletal health outcomes in children, adolescents, and young adults living with HIV: A systematic review.
    PLoS One. 2018;13:e0207022.
    PubMed     Text format     Abstract available
    
    
51. VOURLI G, Nikolopoulos G, Paparizos V, Skoutelis A, et al
    HIV cascade of care in Greece: Useful insights from additional stages.
    PLoS One. 2018;13:e0207355.
    PubMed     Text format     Abstract available
    
    
52. BECK KB, Honge BL, Olesen JS, Petersen MS, et al
    Long-term effects of smallpox vaccination on expression of the HIV-1 co-receptor CCR5 in women.
    PLoS One. 2018;13:e0207259.
    PubMed     Text format     Abstract available
    
    
53. HERNANDEZ-ARRIAGA G, Ruglas K, Alas-Pineda C, Chinchilla-Lopez C, et al
    Prevalence of infectious diseases and its associated factors among the blood donors of the Honduran Red Cross - Northern Region between 2014 and 2016.
    PLoS One. 2018;13:e0207338.
    PubMed     Text format     Abstract available
    
    
54. CHOKO AT, Candfield S, Maheswaran H, Lepine A, et al
    The effect of demand-side financial incentives for increasing linkage into HIV treatment and voluntary medical male circumcision: A systematic review and meta-analysis of randomised controlled trials in low- and middle-income countries.
    PLoS One. 2018;13:e0207263.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Pathog

55. MERINDOL N, El-Far M, Sylla M, Masroori N, et al
    HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5alpha, leading to the induction of an antiviral state.
    PLoS Pathog. 2018;14:e1007398.
    PubMed     Text format     Abstract available
    
    
56. TELWATTE S, Lee S, Somsouk M, Hatano H, et al
    Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency.
    PLoS Pathog. 2018;14:e1007357.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

57. LU CL, Pai JA, Nogueira L, Mendoza P, et al
    Relationship between intact HIV-1 proviruses in circulating CD4(+) T cells and rebound viruses emerging during treatment interruption.
    Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1813512115.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

58. HURLEY LP, Allison MA, Dooling KL, O'Leary ST, et al
    Primary care physicians' experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV).
    Vaccine. 2018;36:7408-7414.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: